Biktarvy, formally known as bictegravir sulfate, includes a powerful single-tablet therapy for treating HIV infection. This drug integrates three key antiviral components: bictegravir, emtricitabine, and tenofovir alafenamide. It functions by preventing the virus's ability to multiply within the body, considerably reducing the viral load. For man